Nursing care
Intramuscular Injection Sites: the nurse's role, start to finish
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
The ventrogluteal site is the safest intramuscular injection site for adults, with the vastus lateralis preferred for infants under seven months. The dorsogluteal site is no longer recommended because of its proximity to the sciatic nerve and superior gluteal artery. Site choice depends on muscle mass, medication volume, and the patient's age and mobility.
What the procedure achieves
An intramuscular injection delivers medication into muscle tissue, where a rich blood supply allows faster absorption than the subcutaneous route and a more stable, predictable rate than an IV bolus. Muscle can also tolerate larger volumes and more irritant drugs than fat tissue, which is why vaccines, antipsychotics, and antiemetics are commonly given this way.
Site selection is not interchangeable. The ventrogluteal muscle, in the hip, is now the preferred site for adults and children over seven months because it is free of major nerves and vessels and carries the lowest risk of injury. The vastus lateralis, on the anterolateral thigh, is the site of choice for infants under seven months because their gluteal muscles are underdeveloped. The deltoid suits small-volume injections such as vaccines in adults with adequate muscle mass. The dorsogluteal site, once standard, is no longer used because of its proximity to the sciatic nerve and superior gluteal artery.
Pre-procedure nursing responsibilities
Confirm the order against the six rights: right patient, drug, dose, route, time, and documentation. Check the medication's compatibility with the IM route, since not every parenteral formulation is licensed for it, and verify the patient has no allergy to the drug or its diluent.
Assess the intended site for bruising, induration, infection, or scarring, and rotate sites for patients on repeated IM therapy to prevent tissue damage. Ask about anticoagulant use or bleeding disorders, which may require a smaller gauge needle or firmer post-injection pressure rather than avoiding the route outright. Explain the procedure, including expected sensation, to reduce anxiety and improve muscle relaxation, which lessens pain on injection.
Equipment and positioning
Needle length and gauge depend on site, patient size, and drug viscosity. A 1 to 1.5 inch needle is typical for the ventrogluteal or vastus lateralis site in an adult, and a shorter 5/8 to 1 inch needle for the deltoid, adjusted for body habitus. Gauge is usually 22 to 25 for standard medications and wider for viscous suspensions.
For the ventrogluteal site, position the patient supine or side-lying with the hip and knee slightly flexed, and locate the site by placing the palm on the greater trochanter with fingers pointing toward the patient's head, forming a V between the index and middle fingers. For the vastus lateralis in an infant, the thigh should be relaxed with the nurse stabilizing the limb. Insert at a 90-degree angle to the skin, aspiration is no longer routinely recommended for most vaccines but remains advised for some medications, follow current facility policy, and inject steadily rather than in a rush.
Complications and early signs
Sciatic nerve injury is the most serious risk, historically linked to the dorsogluteal site, and presents as sharp pain, numbness, or weakness radiating down the leg during or after injection. If a patient reports this, stop, withdraw the needle, and notify the provider immediately.
Other complications include local bleeding or haematoma, particularly in anticoagulated patients, abscess formation from poor aseptic technique, and muscle fibrosis or contracture from repeated injections at the same site. Watch for signs of an evolving abscess, redness, warmth, swelling, and fever, over the days following injection. A vasovagal response, with pallor, sweating, and a drop in blood pressure, can occur during or immediately after the injection in anxious patients, so keep them seated or lying down until it passes.
Post-procedure care
Apply gentle pressure with a dry gauze pad after withdrawing the needle; do not massage the site for medications such as iron dextran or depot antipsychotics, where massage can cause tissue irritation or alter absorption. Dispose of the needle in a sharps container immediately, without recapping.
Document the site used, medication, dose, time, and the patient's response, and rotate documented sites for anyone receiving regular IM therapy. Reassess the patient within 15 to 30 minutes for immediate hypersensitivity reactions if the drug carries that risk, and monitor vital signs per facility protocol for medications with known cardiovascular or respiratory effects.
What to teach before discharge
Tell patients to expect mild soreness, redness, or a small lump at the site for a day or two, and that this is normal and not a sign of infection. Advise them to apply a cool compress for comfort in the first hours if needed, and warm compresses later if soreness persists.
Teach the warning signs that require a call to their provider or a return to care: spreading redness, increasing pain, warmth, pus, fever, or any numbness or weakness in the limb. If the patient or a caregiver will be giving future injections at home, such as insulin analogues that are sometimes given IM in specific circumstances or other self-administered drugs, confirm they can demonstrate correct site selection, angle, and needle disposal before they leave.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why is the ventrogluteal site preferred over the dorsogluteal?
The ventrogluteal site is farther from the sciatic nerve and superior gluteal artery, so the risk of nerve injury or intravascular injection is much lower. The dorsogluteal site has fallen out of use in most guidelines for this reason, though some older references still mention it.
What angle should the needle be inserted at for an IM injection?
Insert at 90 degrees to the skin for most adult IM sites, including ventrogluteal, vastus lateralis, and deltoid. This ensures the medication reaches muscle rather than subcutaneous tissue.
Do you need to aspirate before giving an IM injection?
Aspiration is no longer routinely recommended for standard IM injections and most vaccines, since major nerves and vessels are avoided by correct site selection. Some medications and some facility policies still call for it, so check local protocol before assuming it can be skipped.
Which site is used for infants and why?
The vastus lateralis is used for infants under about seven months because their gluteal muscles are not yet developed enough for a safe ventrogluteal injection. It also gives a larger, more accessible muscle mass in a young infant's thigh.
How much medication can safely be given in one IM injection?
Typical adult limits are up to 3 mL in the deltoid and up to 4 to 5 mL in larger muscles such as the ventrogluteal or vastus lateralis, though this varies by source and patient muscle mass. Larger volumes should be split between two sites rather than given as one large injection.
More on pharmacology
Guides on this